يعرض 1 - 10 نتائج من 10 نتيجة بحث عن '"Adil Al Hinai"', وقت الاستعلام: 1.14s تنقيح النتائج
  1. 1
  2. 2
  3. 3

    المساهمون: Hematology

    المصدر: Molecular Oncology, 15(9), 2300-2317. John Wiley & Sons Ltd.
    Molecular Oncology
    Molecular Oncology, Vol 15, Iss 9, Pp 2300-2317 (2021)

    وصف الملف: application/pdf

  4. 4
  5. 5
  6. 6
  7. 7

    المساهمون: VU University medical center, Hematology laboratory, Hematology, CCA - Cancer biology and immunology, CCA - Cancer Treatment and quality of life, Medical oncology laboratory, CCA - Imaging and biomarkers, Amsterdam Neuroscience - Neurodegeneration

    المصدر: HemaSphere. Wolters Kluwer Health
    HemaSphere
    HemaSphere, Vol 5, Iss 7, p e606 (2021)
    HemaSphere, 6(7):e606. Wolters Kluwer Health
    Cucchi, D G J, van Alphen, C, Zweegman, S, van Kuijk, B, Kwidama, Z J, Al Hinai, A, Henneman, A A, Knol, J C, Piersma, S R, Pham, T V, Jimenez, C R, Cloos, J & Janssen, J J W M 2021, ' Phosphoproteomic characterization of primary AML samples and relevance for response toward FLT3-inhibitors ', HemaSphere . https://doi.org/10.1097/HS9.0000000000000606

    وصف الملف: application/pdf

  8. 8

    المساهمون: Hematology laboratory, CCA - Cancer biology and immunology, Hematology, AII - Inflammatory diseases, Clinical Haematology, University of Zurich, Valk, Peter J M, UCL - (SLuc) Centre du cancer, UCL - (SLuc) Service d'hématologie, UCL - SSS/DDUV - Institut de Duve, UCL - SSS/DDUV/MEXP - Médecine expérimentale, UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'hématologie

    المصدر: Jongen-Lavrencic, Mojca; Grob, Tim; Hanekamp, Diana; Kavelaars, François G; Al Hinai, Adil; Zeilemaker, Annelieke; Erpelinck-Verschueren, Claudia A J; Gradowska, Patrycja L; Meijer, Rosa; Cloos, Jacqueline; Biemond, Bart J; Graux, Carlos; van Marwijk Kooy, Marinus; Manz, Markus G; Pabst Müller, Thomas Niklaus; Passweg, Jakob R; Havelange, Violaine; Ossenkoppele, Gert J; Sanders, Mathijs A; Schuurhuis, Gerrit J; ... (2018). Molecular Minimal Residual Disease in Acute Myeloid Leukemia. New England journal of medicine NEJM, 378(13), pp. 1189-1199. Massachusetts Medical Society MMS 10.1056/NEJMoa1716863 <http://dx.doi.org/10.1056/NEJMoa1716863>
    New England Journal of Medicine, 378(13), 1189-1199. Massachussetts Medical Society
    New England journal of medicine, 378(13), 1189-1199. Massachussetts Medical Society
    Jongen-Lavrencic, M, Grob, T, Hanekamp, D, Kavelaars, F G, Al Hinai, A, Zeilemaker, A, Erpelinck-Verschueren, C A J, Gradowska, P L, Meijer, R, Cloos, J, Biemond, B J, Graux, C, van Marwijk Kooy, M, Manz, M G, Pabst, T, Passweg, J R, Havelange, V, Ossenkoppele, G J, Sanders, M A, Schuurhuis, G J, Löwenberg, B & Valk, P J M 2018, ' Molecular Minimal Residual Disease in Acute Myeloid Leukemia ', New England Journal of Medicine, vol. 378, no. 13, pp. 1189-1199 . https://doi.org/10.1056/NEJMoa1716863
    The New England journal of medicine, Vol. 378, no. 13, p. 1189-1199 (2018)

    وصف الملف: application/pdf; NEJMoa1716863.pdf - application/pdf

  9. 9
  10. 10